October 21, 2020October 21, 2020
NanoStilbene Better Than Copaxone at Reducing MS Symptoms in Mouse Model

The nutritional supplement NanoStilbene, developed by Therapeutic Solutions International, worked better to reduce neurological damage and disease symptoms in an animal model of multiple ... Read more
October 21, 2020October 21, 2020
Immune Cells’ Ability to Clear Myelin Debris Is Potential Therapeutic Approach for MS, Mouse Study Shows

Oral administration of trehalose — a sugar molecule found in plants and fungi and reported to have neuroprotective effects — eased symptoms and halted ... Read more
October 20, 2020October 20, 2020
Finding Support in an Online Community

Finding an understanding community makes such a difference to people diagnosed with multiple sclerosis (MS). Our partners, families, children, and friends do their best ... Read more
October 20, 2020October 20, 2020
Aslan Pharmaceuticals to Develop Aslan003 for Autoimmune Conditions

Aslan Pharmaceuticals announced it will develop Aslan003, a potent and highly selective next-generation modulator of the immune system, as a potential therapy for autoimmune ... Read more
October 20, 2020October 20, 2020
Majority of MS Patients in US Report Mistreatment by Caregivers in Survey

In a nationwide survey of caregiver abuse and neglect among Americans with advanced multiple sclerosis (MS), more than half of respondents reported some form of mistreatment, ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Columns

Social Clips

June 26, 2018July 3, 2018

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury

News

A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more

NanoStilbene Better Than Copaxone at Reducing MS Symptoms in Mouse Model

Immune Cells’ Ability to Clear Myelin Debris Is Potential Therapeutic Approach for MS, Mouse Study Shows

Finding Support in an Online Community

Aslan Pharmaceuticals to Develop Aslan003 for Autoimmune Conditions

Majority of MS Patients in US Report Mistreatment by Caregivers in Survey

Majority of MS Patients in US Report Mistreatment by Caregivers in Survey

MS News That Caught My Eye Last Week: Mayzent in the UK, Aubagio and Other DMTs, Unemployment

Eli Lilly Aquires Disarm, Will Develop SARM1 Program for Axonal Degeneration

Variation in Given Gene May Raise Depression Risk Among MS Patients

Peace, My Heart, Peace

Resistance May Be Futile, but the Borg Taught Me Something

Subscribe to our mailing list

Helius to Survey MS Users of Emilyn App in US With Gait Problems for PoNS Device

Mayzent Approved for Active SPMS Patients in England and Wales

New Immune Cells Therapy Found to Suppress MS Symptoms in EAE Mice

Mayzent Approved for Active Secondary Progressive MS in Scotland

Aubagio’s Long-term Benefits Not Influenced by Prior Treatments, Review Finds

Caregivers of Youth With MS, Other Ills Invited to Survey on Mental Health

How to Make Subcutaneous Injections Less Painful

Risk Factors for Unemployment in People With MS Identified in Study

Human Placental Extract Effectively Treats MS Symptoms in Mouse Study

MS News That Caught My Eye Last Week: Comparing DMTs, Myelin Repair, Hypertension

Columns

Finding Support in an Online Community

MS News That Caught My Eye Last Week: Mayzent in the UK, Aubagio and Other DMTs, Unemployment

Peace, My Heart, Peace

Resistance May Be Futile, but the Borg Taught Me Something

Disability Employment Awareness Isn’t Enough to Keep You Working

How to Make Subcutaneous Injections Less Painful

MS News That Caught My Eye Last Week: Comparing DMTs, Myelin Repair, Hypertension

Fighting the Beast

Could Too Many Tattoos Cause MS Trouble?

What No One Tells You After a Diagnosis

MS News That Caught My Eye Last Week: Amalgam Fillings, COVID-19 and MS, Tecfidera Generic

Balance Is Relative

Everything You Wanted to Know About Poo, but I Was Afraid to Write

Is the FDA Changing Course on Amalgam Dental Fillings and MS?

Reclaiming Our Sexual Health

Social Clips

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury

NanoStilbene Better Than Copaxone at Reducing MS Symptoms in Mouse Model

Immune Cells’ Ability to Clear Myelin Debris Is Potential Therapeutic Approach for MS, Mouse Study Shows

Finding Support in an Online Community

Aslan Pharmaceuticals to Develop Aslan003 for Autoimmune Conditions

Majority of MS Patients in US Report Mistreatment by Caregivers in Survey

Majority of MS Patients in US Report Mistreatment by Caregivers in Survey

MS News That Caught My Eye Last Week: Mayzent in the UK, Aubagio and Other DMTs, Unemployment

Eli Lilly Aquires Disarm, Will Develop SARM1 Program for Axonal Degeneration

Variation in Given Gene May Raise Depression Risk Among MS Patients

Peace, My Heart, Peace

Resistance May Be Futile, but the Borg Taught Me Something

Subscribe to our mailing list

Helius to Survey MS Users of Emilyn App in US With Gait Problems for PoNS Device

Mayzent Approved for Active SPMS Patients in England and Wales

New Immune Cells Therapy Found to Suppress MS Symptoms in EAE Mice

Mayzent Approved for Active Secondary Progressive MS in Scotland

Aubagio’s Long-term Benefits Not Influenced by Prior Treatments, Review Finds

Caregivers of Youth With MS, Other Ills Invited to Survey on Mental Health

How to Make Subcutaneous Injections Less Painful

Risk Factors for Unemployment in People With MS Identified in Study

Human Placental Extract Effectively Treats MS Symptoms in Mouse Study

MS News That Caught My Eye Last Week: Comparing DMTs, Myelin Repair, Hypertension

Finding Support in an Online Community

MS News That Caught My Eye Last Week: Mayzent in the UK, Aubagio and Other DMTs, Unemployment

Peace, My Heart, Peace

Resistance May Be Futile, but the Borg Taught Me Something

Disability Employment Awareness Isn’t Enough to Keep You Working

How to Make Subcutaneous Injections Less Painful

MS News That Caught My Eye Last Week: Comparing DMTs, Myelin Repair, Hypertension

Fighting the Beast

Could Too Many Tattoos Cause MS Trouble?

What No One Tells You After a Diagnosis

MS News That Caught My Eye Last Week: Amalgam Fillings, COVID-19 and MS, Tecfidera Generic

Balance Is Relative

Everything You Wanted to Know About Poo, but I Was Afraid to Write

Is the FDA Changing Course on Amalgam Dental Fillings and MS?

Reclaiming Our Sexual Health

10 Mobile Apps for Better Living With MS

4 Ways Ocrevus Can Improve Your Life

Ocrevus Treatment and Side Effects: What’s Important to Know

4 Ways Ocrevus Can Improve Your Life

5 Things to Know About the New MS Drug Ocrevus

9 Drug Approvals That Changed The Future of Medicine

5 Things to Know About the New MS Drug Ocrevus

9 Approved MS Therapies You Should Know About

Ann Romney’s Fight with Multiple Sclerosis

9 Approved MS Therapies You Should Know About

10 Relapsing-Remitting Multiple Sclerosis (RRMS) Therapies

#CMSC16 – MS and Yoga: Author and Instructor Says Ancient Discipline Can Help Patients in Many Ways

#CMSC16 – Country Artist Clay Walker to MS Patients: You’re Going to Be OK

9 Approved MS Therapies You Should Know About

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 1 at #ECTRIMS2015

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury